# Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease

> **NCT00791557** · NA · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Pyoderma Gangrenosum
- Crohn's Disease
- Ulcerative Colitis
- Inflammatory Bowel Disease

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT00791557
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-12
- **Final completion:** 2010-02
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2016-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791557, "Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00791557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*